187 related articles for article (PubMed ID: 27377006)
1. P-gp, MRP2 and OAT1/OAT3 mediate the drug-drug interaction between resveratrol and methotrexate.
Jia Y; Liu Z; Wang C; Meng Q; Huo X; Liu Q; Sun H; Sun P; Yang X; Ma X; Liu K
Toxicol Appl Pharmacol; 2016 Sep; 306():27-35. PubMed ID: 27377006
[TBL] [Abstract][Full Text] [Related]
2. MDR1 and OAT1/OAT3 mediate the drug-drug interaction between puerarin and methotrexate.
Liu Q; Wang C; Meng Q; Huo X; Sun H; Peng J; Ma X; Sun P; Liu K
Pharm Res; 2014 May; 31(5):1120-32. PubMed ID: 24242937
[TBL] [Abstract][Full Text] [Related]
3. Interaction of immunosuppressive drugs with human organic anion transporter (OAT) 1 and OAT3, and multidrug resistance-associated protein (MRP) 2 and MRP4.
El-Sheikh AA; Greupink R; Wortelboer HM; van den Heuvel JJ; Schreurs M; Koenderink JB; Masereeuw R; Russel FG
Transl Res; 2013 Dec; 162(6):398-409. PubMed ID: 24036158
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Methotrexate Uptake via Organic Anion Transporters OAT1 and OAT3 by Glucuronides of Nonsteroidal Anti-inflammatory Drugs.
Iwaki M; Shimada H; Irino Y; Take M; Egashira S
Biol Pharm Bull; 2017; 40(6):926-931. PubMed ID: 28566636
[TBL] [Abstract][Full Text] [Related]
5. JBP485 attenuates vancomycin-induced nephrotoxicity by regulating the expressions of organic anion transporter (Oat) 1, Oat3, organic cation transporter 2 (Oct2), multidrug resistance-associated protein 2 (Mrp2) and P-glycoprotein (P-gp) in rats.
Wen S; Wang C; Huo X; Meng Q; Liu Z; Yang S; Zhu Y; Sun H; Ma X; Liu K
Toxicol Lett; 2018 Oct; 295():195-204. PubMed ID: 29964132
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate-bestatin interaction: involvement of P-glycoprotein and organic anion transporters in rats.
Zhu Y; Meng Q; Wang C; Liu Q; Huo X; Zhang A; Sun P; Sun H; Li H; Liu K
Int J Pharm; 2014 Apr; 465(1-2):368-77. PubMed ID: 24530518
[TBL] [Abstract][Full Text] [Related]
7. Effect of methotrexate treatment on expression levels of multidrug resistance protein 2, breast cancer resistance protein and organic anion transporters Oat1, Oat2 and Oat3 in rats.
Shibayama Y; Ushinohama K; Ikeda R; Yoshikawa Y; Motoya T; Takeda Y; Yamada K
Cancer Sci; 2006 Nov; 97(11):1260-6. PubMed ID: 16925582
[TBL] [Abstract][Full Text] [Related]
8. Puerarin improves methotrexate-induced renal damage by up-regulating renal expression of Oat1 and Oat3 in vivo and in vitro.
Liu Q; Liu Z; Huo X; Wang C; Meng Q; Sun H; Sun P; Peng J; Ma X; Liu K
Biomed Pharmacother; 2018 Jul; 103():915-922. PubMed ID: 29710508
[TBL] [Abstract][Full Text] [Related]
9. Coadministration of vindesine with high-dose methotrexate therapy increases acute kidney injury via BCRP, MRP2, and OAT1/OAT3.
Huang C; Xia F; Xue L; Liu L; Bian Y; Jin Z; Miao L
Cancer Chemother Pharmacol; 2020 Feb; 85(2):433-441. PubMed ID: 31691080
[TBL] [Abstract][Full Text] [Related]
10. Renal expression of organic anion transporters is modified after mercuric chloride exposure: Gender-related differences.
Hazelhoff MH; Bulacio RP; Chevalier A; Torres AM
Toxicol Lett; 2018 Oct; 295():390-396. PubMed ID: 30031051
[TBL] [Abstract][Full Text] [Related]
11. Effect of JBP485 on obstructive jaundice is related to regulation of renal Oat1, Oat3 and Mrp2 expression in ANIT-treated rats.
Liu T; Guo X; Meng Q; Wang C; Liu Q; Sun H; Ma X; Kaku T; Liu K
Peptides; 2012 Jul; 36(1):78-85. PubMed ID: 22521734
[TBL] [Abstract][Full Text] [Related]
12. PEPT1- and OAT1/3-mediated drug-drug interactions between bestatin and cefixime in vivo and in vitro in rats, and in vitro in human.
Wang L; Wang C; Liu Q; Meng Q; Huo X; Sun P; Yang X; Sun H; Zhen Y; Peng J; Ma X; Liu K
Eur J Pharm Sci; 2014 Oct; 63():77-86. PubMed ID: 25016073
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of JBP485 on renal excretion of acyclovir by the inhibition of OAT1 and OAT3.
Ye J; Liu Q; Wang C; Meng Q; Peng J; Sun H; Kaku T; Liu K
Eur J Pharm Sci; 2012 Sep; 47(2):341-6. PubMed ID: 22728397
[TBL] [Abstract][Full Text] [Related]
14. In vitro risk assessment of AZD9056 perpetrating a transporter-mediated drug-drug interaction with methotrexate.
Elsby R; Fox L; Stresser D; Layton M; Butters C; Sharma P; Smith V; Surry D
Eur J Pharm Sci; 2011 May; 43(1-2):41-9. PubMed ID: 21440623
[TBL] [Abstract][Full Text] [Related]
15. Bezafibrate-mizoribine interaction: Involvement of organic anion transporters OAT1 and OAT3 in rats.
Feng Y; Wang C; Liu Q; Meng Q; Huo X; Liu Z; Sun P; Yang X; Sun H; Qin J; Liu K
Eur J Pharm Sci; 2016 Jan; 81():119-28. PubMed ID: 26474691
[TBL] [Abstract][Full Text] [Related]
16. Cetuximab Prevents Methotrexate-Induced Cytotoxicity in Vitro through Epidermal Growth Factor Dependent Regulation of Renal Drug Transporters.
Caetano-Pinto P; Jamalpoor A; Ham J; Goumenou A; Mommersteeg M; Pijnenburg D; Ruijtenbeek R; Sanchez-Romero N; van Zelst B; Heil SG; Jansen J; Wilmer MJ; van Herpen CML; Masereeuw R
Mol Pharm; 2017 Jun; 14(6):2147-2157. PubMed ID: 28493713
[TBL] [Abstract][Full Text] [Related]
17. OAT1 and OAT3 also mediate the drug-drug interaction between piperacillin and tazobactam.
Wen S; Wang C; Duan Y; Huo X; Meng Q; Liu Z; Yang S; Zhu Y; Sun H; Ma X; Yang S; Liu K
Int J Pharm; 2018 Feb; 537(1-2):172-182. PubMed ID: 29277663
[TBL] [Abstract][Full Text] [Related]
18. Smilax glabra Rhizoma affects the pharmacokinetics and tissue distribution of methotrexate by increasing the P‑glycoprotein mRNA expression in rats after oral administration.
Li Y; Deng S; Ζhao Y; Liu L; Zhao R
Mol Med Rep; 2017 Nov; 16(5):7633-7640. PubMed ID: 28944899
[TBL] [Abstract][Full Text] [Related]
19. OAT1 and OAT3: targets of drug-drug interaction between entecavir and JBP485.
Xu Q; Wang C; Meng Q; Liu Q; Sun H; Peng J; Ma X; Kaku T; Liu K
Eur J Pharm Sci; 2013 Mar; 48(4-5):650-7. PubMed ID: 23313623
[TBL] [Abstract][Full Text] [Related]
20. Quantitative evaluation of the drug-drug interactions between methotrexate and nonsteroidal anti-inflammatory drugs in the renal uptake process based on the contribution of organic anion transporters and reduced folate carrier.
Nozaki Y; Kusuhara H; Endou H; Sugiyama Y
J Pharmacol Exp Ther; 2004 Apr; 309(1):226-34. PubMed ID: 14722319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]